These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8895155)

  • 1. Procollagen II C-propeptide in joint fluid: changes in concentration with age, time after knee injury, and osteoarthritis.
    Lohmander LS; Yoshihara Y; Roos H; Kobayashi T; Yamada H; Shinmei M
    J Rheumatol; 1996 Oct; 23(10):1765-9. PubMed ID: 8895155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
    Lohmander LS; Ionescu M; Jugessur H; Poole AR
    Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal patterns of stromelysin-1, tissue inhibitor, and proteoglycan fragments in human knee joint fluid after injury to the cruciate ligament or meniscus.
    Lohmander LS; Roos H; Dahlberg L; Hoerrner LA; Lark MW
    J Orthop Res; 1994 Jan; 12(1):21-8. PubMed ID: 8113939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis.
    Lohmander LS; Atley LM; Pietka TA; Eyre DR
    Arthritis Rheum; 2003 Nov; 48(11):3130-9. PubMed ID: 14613275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.
    Garnero P; Ayral X; Rousseau JC; Christgau S; Sandell LJ; Dougados M; Delmas PD
    Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of the levels of carboxy terminal type II procollagen peptide, chondroitin sulfate isomers, tissue inhibitor of metalloproteinases, and metalloproteinases in osteoarthritis joint fluid.
    Shinmei M; Kobayashi T; Yoshihara Y; Samura A
    J Rheumatol Suppl; 1995 Feb; 43():78-81. PubMed ID: 7752146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synovial fluid concentrations of the C-propeptide of type II collagen correlate with body mass index in primary knee osteoarthritis.
    Kobayashi T; Yoshihara Y; Samura A; Yamada H; Shinmei M; Roos H; Lohmander LS
    Ann Rheum Dis; 1997 Aug; 56(8):500-3. PubMed ID: 9306875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical usefulness of the measurement of type-II procollagen carboxypeptide (C-II propeptide, pColl-II-C) in synovial fluid as a marker of collagen metabolism in cartilage].
    Shinmei M; Nagaya I; Miyanaga Y; Iwata H; Yamamoto S; Torisu T; Fujii K; Fukubayashi T; Kondo M; Kurosaka M
    Ryumachi; 1992 Oct; 32(5):453-60. PubMed ID: 1440081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.
    Squires GR; Okouneff S; Ionescu M; Poole AR
    Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis.
    Ishiguro N; Ito T; Ito H; Iwata H; Jugessur H; Ionescu M; Poole AR
    Arthritis Rheum; 1999 Jan; 42(1):129-36. PubMed ID: 9920023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N; Juillet F; Garnero P
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synovial fluid cartilage metabolism marker concentrations in osteonecrosis of the femoral head compared with osteoarthrosis of the hip.
    Iwase T; Hasegawa Y; Ishiguro N; Ito T; Iwasada S; Kitamura S; Iwata H
    J Rheumatol; 1998 Mar; 25(3):527-31. PubMed ID: 9517775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenascin-C levels in synovial fluid are elevated after injury to the human and canine joint and correlate with markers of inflammation and matrix degradation.
    Chockalingam PS; Glasson SS; Lohmander LS
    Osteoarthritis Cartilage; 2013 Feb; 21(2):339-45. PubMed ID: 23142724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Levels of chondroitin 4-sulfate, chondroitin 6-sulfate and carboxy-terminal type II procollagen peptide in knee synovial fluid after injury to the anterior cruciate ligament].
    Yoshihara Y; Yamada H; Miyauchi S; Ito K; Samura A; Shinmei M
    Ryumachi; 1996 Oct; 36(5):734-40. PubMed ID: 8969551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated clearance of albumin from the osteoarthritic knee: implications for interpretation of concentrations of "cartilage markers" in synovial fluid.
    Myers SL; O'Connor BL; Brandt KD
    J Rheumatol; 1996 Oct; 23(10):1744-8. PubMed ID: 8895152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis.
    Tchetverikov I; Lohmander LS; Verzijl N; Huizinga TW; TeKoppele JM; Hanemaaijer R; DeGroot J
    Ann Rheum Dis; 2005 May; 64(5):694-8. PubMed ID: 15834054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased concentrations of bone sialoprotein in joint fluid after knee injury.
    Lohmander LS; Saxne T; Heinegård D
    Ann Rheum Dis; 1996 Sep; 55(9):622-6. PubMed ID: 8882132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis.
    Lohmander LS; Saxne T; Heinegård DK
    Ann Rheum Dis; 1994 Jan; 53(1):8-13. PubMed ID: 8311563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.